Because it is rapidly increased within 3 h after myocardial ischemic injury [9], studies have reported that H-FABP is a promising biomarker for acute coronary syndrome (ACS) and cardiac dysfunction [20]. The gene discussed is FABP3; the disease is acute coronary syndrome.